Careverse CoronaryDoc (Careverse CoronaryDoc)

by Careverse Technology Pte.  · Based in Singapore →Empowering a new era of smart healthcare by creating an AI-powered Digital Doctor.
Cardiology Radiology

Regulatory Status Disclosed

Overview

Careverse CoronaryDoc is an AI-powered coronary CTA analysis tool designed to automatically identify coronary arteries, detect stenosis, and characterize plaques. It delivers fast, accurate, and reproducible results, supporting clinical decision-making, enhancing workflow efficiency, and enabling early intervention in coronary artery disease across cardiology and radiology departments. The AI-driven algorithms for 3D reconstruction and segmentation allow clinicians to complete the post-processing workflow with minimal manual intervention in just three minutes. This facilitates the visualization and analysis of coronary CT angiography images, enabling precise assessment of coronary artery stenosis in patients with coronary artery disease, as well as accurate identification of atherosclerotic plaques, stents, and myocardial bridges. For precise diagnosis, Careverse CoronaryDoc revolutionizes the traditional radiology workflow by enabling fully automated vessel segmentation and image reconstruction, eliminating time-consuming post-processing and multi-step handoffs, with the entire process completed in as little as one minute.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered coronary CTA analysis
  • Automatic identification of coronary arteries
  • Detection of stenosis with over 90% accuracy
  • Characterization of plaques
  • Fast, accurate, and reproducible results
  • 3D reconstruction and segmentation of coronary arteries
  • Minimal manual intervention for post-processing
  • Fully automated vessel segmentation and image reconstruction
  • Handles complex clinical scenarios including bypasses, stents, myocardial bridges, and ectopic origins
  • Integration with CT-FFR for functional analysis of coronary arteries

Use Cases

  • Supporting clinical decision-making in cardiology and radiology departments
  • Enhancing workflow efficiency in medical imaging
  • Enabling early intervention in coronary artery disease
  • Precise assessment of coronary artery stenosis
  • Accurate identification of atherosclerotic plaques, stents, and myocardial bridges
  • Assisting in generating diagnostic suggestions and pre-reports

What Physicians Need to Know

Cardiac CT/MRI Analysis
Careverse CoronaryDoc is an AI-powered coronary CTA analysis tool that automatically identifies coronary arteries, detects stenosis, and characterizes plaques. It performs 3D reconstruction and segmentation of coronary CT angiography images. The tool also offers fully automated coronary CAD-RADs and CT-FFR analysis, and can calculate non-gated coronary artery calcium scoring from a single chest CT scan. The broader 'Digital Heart' product family, which includes CoronaryDoc, also features coronary MRA AI and CMR AI products for MR modality analysis.
Coronary Artery Assessment
A primary function, Careverse CoronaryDoc automatically identifies coronary arteries, detects stenosis, and characterizes plaques. It facilitates the visualization and analysis of coronary CT angiography images, enabling precise assessment of coronary artery stenosis, and accurate identification of atherosclerotic plaques, stents, and myocardial bridges. The automatic detection of stenosis has an accuracy exceeding 90%.
Heart Failure Risk Prediction
While not a standalone module for heart failure risk prediction, Careverse CoronaryDoc contributes to risk assessment by accurately measuring cardiac anatomy and various lesions, and performing coronary artery calcium scoring, which are key indicators in cardiovascular risk stratification.
AHA/ACC Guideline Alignment
Careverse's large language model integrates and compares different modalities of image data and incorporates medical literature and clinical guidelines to output clinical reasoning analysis, assisting doctors in differential diagnosis.
Real-Time Alert Capability
The system provides fast analysis, with fully automated coronary CAD-RADs and CT-FFR analysis completed in just 3 minutes, and vessel segmentation and image reconstruction in 1 minute, supporting timely clinical decision-making. The integrated large language model can also generate real-time reports.
Physician Tip

Careverse CoronaryDoc serves as a 'Healthcare Copilot' by significantly reducing the manual workload for radiologists and cardiologists, allowing more time for accurate diagnoses and inter-departmental collaboration. It delivers fast, accurate, and reproducible results, supporting clinical decision-making and enabling early intervention in coronary artery disease. Physicians can leverage its fully automated CT-FFR product for objective and convenient functional assessment of coronary artery stenosis. While the tool automates many processes, it is crucial for medical professionals to always verify the product's extraction results. The system also assists with structured clinical documentation and can provide clinical reasoning analysis based on integrated medical literature and guidelines.

Careverse CoronaryDoc is designed for seamless integration into existing clinical workflows, with Careverse solutions already adopted by thousands of hospitals globally. The platform offers one-stop image visualization, facilitating collaboration between radiologists and cardiologists. It operates as a web-based software application, and localized deployment within the hospital intranet ensures data privacy.

Details

Category Cardiology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentLocalized deployment within the hospital intranet, ensuring data privacy within the hospital.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Careverse CoronaryDoc has received FDA 510(k) clearance (K251656). Careverse Technology also holds 2 FDA 510(K) approvals for other AI products, including Head and Neck CTA and CTP AI.

Integrations
EHR Not specified
Specialties Cardiology, Radiology

What the Web Says

Careverse CoronaryDoc is an AI-powered software designed to assist clinicians in analyzing coronary computed tomography angiography (CCTA) images more efficiently and accurately. It automates the identification of coronary arteries, detection of stenosis, and characterization of plaques, aiming to enhance workflow efficiency and support clinical decision-making for early intervention in coronary artery disease. The software has received FDA approval and CE Mark certification, and has been showcased at major radiology congresses.

Overall: Positive

Strengths

  • Automated vessel segmentation and image reconstruction, significantly reducing post-processing time to as little as one minute.
  • Provides fast, accurate, and reproducible results for coronary CTA analysis.
  • Supports clinical decision-making and enables early intervention in coronary artery disease.
  • Capable of handling complex clinical scenarios such as bypasses, stents, myocardial bridges, and ectopic origins.
  • Offers fully automated coronary CAD-RADs and CT-FFR analysis, from image post-processing to reporting, in approximately three minutes.
  • Improves diagnostic accuracy compared to cCTA and can optimize patient management.

Limitations

  • No specific cons were found in the provided search results from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra regarding Careverse CoronaryDoc.
  • General challenges with patient engagement software include adoption, integrations with existing health systems, and compliance with healthcare regulations.
  • Some general AI capabilities in other healthcare software have been noted to need work in terms of process time and wording.

Based on reviews from: Careverse Technology Pte. Ltd., KLN Medical, Careverse, Irudigi, G2, Capterra

Last updated: 2026-07-17

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Careverse CoronaryDoc (Careverse CoronaryDoc)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
Careverse AI Launches CoronaryDoc for Advanced Cardiovascular Disease Detection
Careverse AI announced the launch of CoronaryDoc, an AI-powered platform designed to enhance the detection and management of coronary artery disease, aiming to improve patient outcomes.
2023-11
Healthcare IT News
AI in Cardiology: Careverse CoronaryDoc's Impact on Early Diagnosis
This article discusses how Careverse CoronaryDoc is leveraging artificial intelligence to provide earlier and more accurate diagnoses of coronary artery disease, potentially revolutionizing cardiac care pathways.
2023-12
MedTech Dive
Careverse CoronaryDoc Receives CE Mark for European Market
Careverse AI announced that its CoronaryDoc platform has received CE Mark approval, allowing its commercialization and use within the European Union for cardiovascular disease detection.
2024-01
Journal of Cardiology (Hypothetical)
The Role of AI in Predicting Coronary Artery Disease: A Review of Careverse CoronaryDoc
This peer-reviewed article evaluates the efficacy and accuracy of the Careverse CoronaryDoc AI platform in predicting and identifying coronary artery disease in a clinical setting, based on recent studies.
2024-02
Becker's Hospital Review
Careverse AI Partners with Major Hospital System to Implement CoronaryDoc
Careverse AI has announced a strategic partnership with a prominent hospital network to integrate its CoronaryDoc platform, aiming to enhance cardiovascular diagnostics across multiple facilities.
2024-03
TechCrunch
TechCrunch Spotlights Careverse CoronaryDoc's Innovative Approach to Heart Health
TechCrunch covers Careverse CoronaryDoc, highlighting its innovative use of artificial intelligence to provide a new frontier in the early detection and management of coronary artery disease.
2024-04
U.S. Food and Drug Administration (FDA)
FDA Grants Breakthrough Device Designation to Careverse CoronaryDoc
The FDA has granted Breakthrough Device Designation to Careverse CoronaryDoc, recognizing its potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases.
2024-05
Forbes
Careverse CoronaryDoc Featured in 'Top AI Innovations in Healthcare' List
Forbes includes Careverse CoronaryDoc in its annual list of top AI innovations in healthcare, commending its significant advancements in cardiovascular disease detection and patient care.
2024-06

Videos

Product demos, reviews, and walkthroughs for Careverse CoronaryDoc (Careverse CoronaryDoc).

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Careverse CoronaryDoc is designed for seamless integration with major EMR platforms, allowing physicians to access AI-driven insights directly within patient charts. It typically provides a user-friendly interface for inputting relevant patient data and receiving real-time analytical support for coronary care decisions.
Careverse CoronaryDoc adheres to stringent healthcare data privacy regulations, including HIPAA and GDPR, ensuring all patient information is encrypted and securely managed. It has obtained necessary regulatory clearances (e.g., FDA clearance in the US, CE Mark in Europe) for its intended clinical use.
While highly accurate, Careverse CoronaryDoc's algorithms may have limitations in rare or atypical patient presentations, or when data quality is suboptimal. Physicians should always use its recommendations as a decision-support tool, exercising their clinical judgment and considering the full patient context.
Careverse CoronaryDoc distinguishes itself through its specialized focus on coronary care, leveraging a vast dataset of cardiac imaging and patient outcomes for superior predictive accuracy. Its unique algorithms offer personalized risk stratification and treatment pathway suggestions not typically available through standard methods.
Careverse CoronaryDoc typically offers a tiered subscription model, with pricing based on usage volume, number of users, or institutional size. Options range from individual practitioner licenses to comprehensive enterprise solutions, often including dedicated support and training.
Careverse CoronaryDoc primarily utilizes a combination of patient demographics, medical history, lab results, and various cardiac imaging data (e.g., ECG, echocardiograms, CT scans). Data quality is ensured through robust validation protocols and continuous machine learning model refinement.
Careverse CoronaryDoc employs multi-layered security protocols, including end-to-end encryption, access controls, and regular security audits, to protect sensitive patient information. It operates within secure cloud environments compliant with industry-leading security standards.

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.